Recombinant Human PGK1 Protein，GST

PGK1, or phosphoglycerate kinase 1, is a crucial glycolytic enzyme that plays a significant role in cellular metabolism by catalyzing the conversion of 1,3-bisphosphoglycerate to 3-phosphoglycerate, while facilitating the transfer of a phosphate group to ADP, resulting in ATP generation. The importance of PGK1 extends beyond its metabolic function, as its expression and activity have been linked to various physiological and pathological conditions, including cancer, where altered glycolytic pathways contribute to tumor growth and survival. Research into recombinant PGK1 has gained prominence due to its potential applications in biotechnology and medicine. Producing PGK1 as a recombinant protein allows for in-depth structural and functional studies, aiding in the understanding of its catalytic mechanism and regulation. Furthermore, PGK1 is being investigated as a potential biomarker for certain diseases and a target for therapeutic interventions. The protein's involvement in metabolic disorders also highlights its significance in developing strategies for disease management. Advances in recombinant DNA technology enable efficient production and purification of PGK1, facilitating high-throughput assays and drug screening. Overall, PGK1 research not only enriches our knowledge of fundamental metabolic processes but also opens avenues for innovative therapeutic approaches, making it a compelling subject for ongoing scientific investigation.